Marafini, I., Stolfi, C., Troncone, E., Lolli, E., Onali, S., Paoluzi, O. A., . . . Monteleone, G. (2021). A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study. BioDrugs.
Dyfyniad Arddull ChicagoMarafini, Irene, et al. "A Pharmacological Batch of Mongersen That Downregulates Smad7 Is Effective As Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study." BioDrugs 2021.
Dyfyniad MLAMarafini, Irene, et al. "A Pharmacological Batch of Mongersen That Downregulates Smad7 Is Effective As Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study." BioDrugs 2021.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.